Alnylam announces 2021 product and pipeline goals and provides program updates at r&d day

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, is kicking off a virtual r&d day event today. during the two-day event, the company plans to showcase its commercial and r&d progress, including its product and pipeline goals for 2021, focused on continued commercial execution and advancement of early-, mid- and late-stage investigational programs. alnylam will also provide an update on its progress toward achieving a
ALNY Ratings Summary
ALNY Quant Ranking